Pembrolizumab for advanced urothelial carcinoma: exploratory ctDNA biomarker analyses of the KEYNOTE-361 phase 3 trialThomas Powles, Şeyda Gündüz, Yen‐Hwa Chang et al.|Nature Medicine|2024Cited by 35
Inhibition of in vitro and in vivo T cell responses by recombinant human Tim-1 extracellular domain proteinsMehdi Mesri, Gary C. Starling, Suresh Shenoy et al.|International Immunology|2006Cited by 21